MDL Centralization Sought For Suits Asserting That Dupixent Causes Cancer
WASHINGTON, D.C. — Cases alleging that Dupixent, a prescription medication used for the treatment of asthma and inflammatory skin conditions, may cause cutaneous T-cell lymphoma (CTCL), a rare type of cancer...To view the full article, register now.
Already a subscriber? Click here to view full article